Tocci G, Visco G
Clin Ter. 1989 Jan 15;128(1):13-20.
In order to evaluate effectiveness and tolerance of treatment with 300 mg tablets of enoxacine (one every 12 hours), 30 patients between the ages of 29 and 75 were selected (51.23 +/- 2.19 yrs. was the average age), 4 males and 26 females; 18 patients had acute cystitis, 7 had pyelonephritis, 4 had cystopyelitis, and 1 had urethroprostatitis. Treatment lasted on average of 10.77 +/- 0.52 days, with a minimum of 7 and a maximum of 20 days. Initial culture analysis of urine samples ascertained the presence of microbial pathogens sensitive to enoxacine. After one week of treatment, culture analysis of urine samples did not reveal the presence of these pathogens, all having been successfully eliminated. The improvement of the objective and symptomatic parameters chosen for evaluating the effectiveness of the treatment was found to be rapid and decisive in the majority of patients. The systemic tolerance was good; the side effects were minimal (three cases of slight gastroenteric intolerance). At the end of treatment, results were considered excellent in 18 patients and good in 12, on the basis of the more or less rapid resolution of the clinical and symptomatic situation.
为评估 300 毫克依诺沙星片剂(每 12 小时 1 片)治疗的有效性和耐受性,选取了 30 例年龄在 29 至 75 岁之间的患者(平均年龄为 51.23±2.19 岁),其中男性 4 例,女性 26 例;18 例患有急性膀胱炎,7 例患有肾盂肾炎,4 例患有膀胱肾盂炎,1 例患有尿道前列腺炎。治疗平均持续 10.77±0.52 天,最短 7 天,最长 20 天。对尿液样本进行的初始培养分析确定了存在对依诺沙星敏感的微生物病原体。治疗一周后,尿液样本的培养分析未发现这些病原体,所有病原体均已成功清除。在大多数患者中,发现为评估治疗有效性而选定的客观和症状参数改善迅速且显著。全身耐受性良好;副作用轻微(3 例轻度胃肠不耐受)。治疗结束时,根据临床和症状情况的或多或少快速缓解情况,18 例患者结果被评为优秀,12 例患者结果被评为良好。